2024/05/07 by Antonio González-Martı́n, Antonio González-Martín, Hyun Cheol Chung +17 · 24 citations
Medicine · #Cancer #Cancer Immunotherapy and Biomarkers #Clinical trial #Gynecology #Immunotherapy #Internal medicine #Lenvatinib #Medicine #Oncology #Ovarian cancer #Ovarian cancer diagnosis and treatment #PARP inhibition in cancer therapy #Pembrolizumab #Phases of clinical research
paper · pdf · doi:10.1016/j.ygyno.2024.04.011
published in Gynecologic Oncology 186, 182-190 (Elsevier BV)
openalex publication_date 2024/05/07 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28